CSL CEO McNamee on Business Outlook
Feb. 13 (Bloomberg) -- Brian McNamee, chief executive officer of CSL Ltd., Australia’s biggest pharmaceutical company, talks about the its financial performance and business outlook.
CSL reported a 24 percent jump in first-half profit as demand for blood-derived treatments increased. McNamee speaks with Susan Li on Bloomberg Television's "First Up." (Source: Bloomberg)